Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE) have recently come under scrutiny following President Trump’s executive order directing drugmakers to lower medicine prices to match what ...

Trump signs executive order setting 30-day deadline for drugmakers to lower prescription drug costs. Drugmakers aren't happy.

The U.S., Trump said, would no longer pay more than "the Nation that pays the lowest price anywhere in the World." ...

(Jim Watson/Agence France-Presse/Getty Images) Drugmakers' shares fell globally after President Trump said he would sign an executive order to lower the cost of prescription drugs. The share-price ...

despite President Donald Trump announcing plans to bring drug prices down. Eli Lily shares fell by about 3% premarket, while shares of Pfizer and Merck were down more than 2% before rebounding in ...

Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...

Pfizer will pay $1.25 billion upfront to license an experimental cancer drug out of China ... Citigroup raised 3SBio’s price target to HK$21.00 ($2.7) from HK$13.00 after the deal.